Skip to main content

Peer Review reports

From: Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Original Submission
28 Feb 2024 Submitted Original manuscript
1 Mar 2024 Author responded Author comments - Pontus Plavén-Sigray
Resubmission - Version 2
1 Mar 2024 Submitted Manuscript version 2
8 Mar 2024 Editorially accepted
4 Apr 2024 Article published 10.1186/s12883-024-03596-1

You can find further information about peer review here.

Back to article page